Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Biopharmacon, AB

Closing information (x1000 SEK)

Closing information 2025/06 2024/06 2023/06
Turnover 366 More Arrow 480 Less Arrow 382
Financial expenses 3 More Arrow 5 Less Arrow 0
Earnings before taxes 98 More Arrow 225 Less Arrow 21
EBITDA -53 More Arrow 62 Less Arrow -35
Total assets 7,035 More Arrow 7,075 Less Arrow 6,807
Current assets 6,623 More Arrow 6,659 Less Arrow 6,386
Current liabilities 94 More Arrow 166 Less Arrow 86
Equity capital 6,901 Less Arrow 6,826 Less Arrow 6,650
- share capital 100 Equal arrow 100 Equal arrow 100
Employees (average) 1 Equal arrow 1 Equal arrow 1

Financial ratios

Fiscal year 2025/06 2024/06 2023/06
Solvency 98.1% Less Arrow 96.5% More Arrow 97.7%
Turnover per employee 366 More Arrow 480 Less Arrow 382
Profit as a percentage of turnover 26.8% More Arrow 46.9% Less Arrow 5.5%
Return on assets (ROA) 1.4% More Arrow 3.3% Less Arrow 0.3%
Current ratio 7045.7% Less Arrow 4011.4% More Arrow 7425.6%
Return on equity (ROE) 1.4% More Arrow 3.3% Less Arrow 0.3%
Change turnover -114 More Arrow 98 More Arrow 139
Change turnover % -24% More Arrow 26% More Arrow 57%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees % 0% Equal arrow 0% Equal arrow 0%

Total value of public sale

Fiscal year 2025/06 2024/06 2023/06
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.